A Case Study - NeuBase Therapeutics, Inc.
NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.
Keyword(s):
2014 ◽
Vol 53
(2)
◽
pp. R47-R59
◽
2020 ◽
Vol 2020
◽
pp. 1-6
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 163
◽
pp. 538-545
◽
2005 ◽
Vol 285
(1)
◽
pp. 138-155
◽